Top Suppliers:I want be here



100202-39-9

100202-39-9 structure
100202-39-9 structure
  • Name: Methyl azetidine-3-carboxylate hydrochloride
  • Chemical Name: Methyl azetidine-3-carboxylate hydrochloride
  • CAS Number: 100202-39-9
  • Molecular Formula: C5H10ClNO2
  • Molecular Weight: 151.591
  • Catalog: Chemical reagent Organic reagent Ester Other ester compounds
  • Create Date: 2018-07-01 20:23:12
  • Modify Date: 2024-01-02 09:13:41
  • Methyl azetidine-3-carboxylate hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Methyl azetidine-3-carboxylate hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs<

Name Methyl azetidine-3-carboxylate hydrochloride
Synonyms Azetidine-3-carboxylic Acid Methyl Ester Hydrochloride
3-Azetidinecarboxylic acid, methyl ester, hydrochloride (1:1)
Methyl 3-azetidinecarboxylate hydrochloride (1:1)
Methyl Azetidine-3-carboxylate Hydrochloride
Methyl 3-azetidinecarboxylate hydrochloride
Methyl azetidine-3-carboxylate hydrochloride (1:1)
methyl azetidine-3-carboxylate,hydrochloride
methylazetidine-3-carboxylatehydrochloride
Description Methyl azetidine-3-carboxylate hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Methyl azetidine-3-carboxylate hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs<
Related Catalog
Target

Non-cleavable

In Vitro ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1]. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2].
References

[1]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017;16(5):315-337.

[2]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985.

Boiling Point 190.9ºC at 760 mmHg
Melting Point 93.0 to 97.0 °C
Molecular Formula C5H10ClNO2
Molecular Weight 151.591
Flash Point 69.3ºC
Exact Mass 151.040009
PSA 38.33000
LogP 0.50960
Hazard Codes Xi
Risk Phrases 36
Safety Phrases 26
HS Code 2933990090

~99%

100202-39-9 structure

100202-39-9

Literature: Eisai RandD Management Co., Ltd. Patent: EP1889836 A1, 2008 ; Location in patent: Page/Page column 80 ;

~99%

100202-39-9 structure

100202-39-9

Literature: PFIZER INC.; BROWN, Matthew, Frank; MITTON-FRY, Mark. J.; HAN, Seungil; LALL, Manjinder; PLUMMER, Mark, Stephen; RISLEY, Hud, Lawrence; SHANMUGASUNDARAM, Veerabahu; STARR, Jeremy, T. Patent: WO2012/73138 A1, 2012 ; Location in patent: Page/Page column 55-56 ; WO 2012/073138 A1

~99%

100202-39-9 structure

100202-39-9

Literature: Pfizer Products Inc. Patent: EP978279 A1, 2000 ;
HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%